You searched for "quality"

1217 results found

Prostaglandin-associated periorbitopathy

This is a masked study of 33 patients who had been taking a prostaglandin analogue in one eye only for at least a year, to look for signs of prostaglandin-associated periorbitopathy (PAP). The investigators devised a new grading system to...

What's trending Apr/May 2022

A round-up of the eye-related hot topics that have been trending over the last few weeks. #ArgusI #ArgusII #bioniceye #retinitispigmentosa #SecondSight Remember Argus I & Argus II? Its star burned bright, touted as the future of treatment for retinitis pigmentosa....

The 2021-2022 ophthalmology ST1 application process

Harry Rosen updates us on what is involved in the current UK Ophthalmology Specialist Training (OST) programme application process. The process of applying to the UK Ophthalmology Specialist Training (OST) programme is constantly changing each year, adapting to the needs...

Capacity-building through the COECSA-RCOphth LINK – linking journals in a training and mentorship programme

The College of Ophthalmology of Central, Eastern and Southern Africa (COECSA) [1] and the Royal College of Ophthalmologists (RCOphth) [2] have a long-standing health partnership through the VISION 2020 LINKS Programme [3,4]. The LINK started a new project in 2019...

The role of virtual Rb-NET Multidisciplinary Team meetings in the management of children with retinoblastoma in low- and middle-income countries

A selection of participants in an MDT meeting with Uganda. In 2017 the LINKS Programme developed a new network of LINKS to support and coordinate action against retinoblastoma (Rb) in response to requests from low- and middle-income countries (LMICs), called...

Paediatric ophthalmology training in Africa through the Juba-Bournemouth VISION 2020 LINK

One of the aims of the College of Ophthalmology of Eastern, Central and Southern Africa (COECSA) is to provide specialist ophthalmic training for practising ophthalmologists from its 11 member countries. A number of initiatives are enabling more ophthalmologists to undertake...

Are we short-sighted about myopia?

Worldwide prevalence of myopia has increased rapidly in recent years and has now reached epidemic levels, particularly in South-East Asia where prevalence is around 80% [1-4]. Myopia prevalence is also increasing in the United States and Europe where it is...

Doing a systematic review: a users’ guide for foundation doctors

Research is increasingly important for junior doctors and systematic reviews (SRs) are a great place to start. Carrying out an SR can help a doctor demonstrate commitment to a specialty, develop research skills and get results quickly. This article aims...

How to examine the visual system Part 1: visual acuity, visual fields and eye movements

Asking candidates to perform an examination of the visual system, either as part of a full cranial nerve exam or as an individual entity, is a common station in practical examinations during medical school. It is important to practise for...

Nurse-led Rapid Corneal Collagen Cross-linking / UKISOP Society Education Day

Nurse-led Rapid Corneal Collagen Cross-linking By Dan Gore Over the last decade, clinical trial data has accumulated for new interventions in keratoconus that promise to arrest disease progression, significantly reduce transplantation rates and save many patients from long-term reliance on...

A missed intraocular telescope – an opportunity to re-focus the evidence

Intraocular telescopes allow magnification of the image so that it would be projected into a larger area of the macula, this makes the central defect caused by dry age-related macular degeneration (AMD) smaller. The most common approach is a Galilean...

Recurrent corneal erosions secondary to isotretinoin use

Isotretinoin (13–cis-retinoic acid) is the first line treatment for moderate to severe nodulocystic or papulopustular acne [1,2]. Although it is a safe medication, it has several adverse side-effects, including ophthalmic manifestations, as shown in Table 1 [3]. These side-effects need...